| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/12/2013 | CA2875247A1 Chimeric clotting factors |
| 12/12/2013 | CA2875246A1 Procoagulant compounds |
| 12/12/2013 | CA2779883A1 Composition |
| 12/11/2013 | EP2671889A2 RF amide-related peptides and methods thereof |
| 12/11/2013 | EP2671614A1 Molecular Targets for Treatment of Inflammation |
| 12/11/2013 | EP2671591A1 Process for the preparation of short-chain peptide powders |
| 12/11/2013 | EP2671584A2 Compositions and methods for treating disorders associated with salt or fluid retention |
| 12/11/2013 | EP2670774A1 Caspase-2 inhibitors |
| 12/11/2013 | EP2670429A2 Method for inactivation/removal of coagulation factors by precipitation |
| 12/11/2013 | EP2670428A1 Use of hgh for the treatment of small for gestational age infants under two years of age |
| 12/11/2013 | EP2670427A1 Prevention of hypoglycaemia in diabetes mellitus type 2 patients |
| 12/11/2013 | EP2670426A2 Multimodal trail molecules and uses in cellular therapies |
| 12/11/2013 | EP2670425A2 Ubiquitin interacting motif peptides as cancer therapeutics |
| 12/11/2013 | EP2670424A2 Cardiotrophin related molecules for enhanced therapeutics |
| 12/11/2013 | EP2670423A2 Use of the sigma-1 receptor for regulating ion channel expression at the post-transcriptional level |
| 12/11/2013 | EP2670422A1 Antagonism of the vip signaling pathway |
| 12/11/2013 | EP2670421A2 Use of icam-1 for prevention or treatment of neurological diseases |
| 12/11/2013 | EP2670420A1 Antiviral agent containing recombinant mistletoe lectins |
| 12/11/2013 | EP2670419A1 Psa capture agents, compositions, methods and preparation thereof |
| 12/11/2013 | EP2670418A1 Orally bioavailable peptide drug compositions and methods thereof |
| 12/11/2013 | EP2670417A1 Methods and compositions for treating bacterial infections with iron chelators |
| 12/11/2013 | EP2670416A1 A novel high affinity bivalent helically constrained peptide against cancer |
| 12/11/2013 | EP2670410A1 Antimicrobial 4-oxoquinolizines |
| 12/11/2013 | EP2670406A1 Combination therapy with interferon and andrographolides for multiple sclerosis |
| 12/11/2013 | EP2670403A1 Methods for treating brain injury |
| 12/11/2013 | EP2295039B1 Method of preparing pancreatin pellets, in particular pancreatin micropellets, and pancreatin pellets prepared thereby |
| 12/11/2013 | CN103443270A Nucleic acid construct for expression of [alpha]-alactosidase in plants and plant cells |
| 12/11/2013 | CN103443269A Bacteriophage lytic enzymes as alternative antimicrobials |
| 12/11/2013 | CN103443119A Cyclosporine analogue molecules modified at amino acid 1 and 3 |
| 12/11/2013 | CN103443118A Novel peptide |
| 12/11/2013 | CN103442768A Compositions and methods for treating cancer |
| 12/11/2013 | CN103442747A Dual drug pen-injection device with micro-reservoirs carrying secondary drug for emergency injection |
| 12/11/2013 | CN103442728A Antibacterial agent for treating infectious diseases of bacterial origin |
| 12/11/2013 | CN103442717A Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases |
| 12/11/2013 | CN103442715A A pharmaceutical composition comprising an HDAC inhibitor and a steroid and the use thereof. |
| 12/11/2013 | CN103442695A Stable formulations for parenteral injection of peptide drugs |
| 12/11/2013 | CN103442595A Functional foods comprising diamine oxidase and uses thereof |
| 12/11/2013 | CN103442592A Use of nutritional compositions including lactoferrin in stimulating immune cells |
| 12/11/2013 | CN103436582A Konjac polypeptide extract, as well as preparation method and application thereof |
| 12/11/2013 | CN103436579A Method for preparing cubilose extract with strong antioxidation |
| 12/11/2013 | CN103436537A Lily ester floral gene LoAAT1 and application thereof |
| 12/11/2013 | CN103436507A Phage derived antimicrobial activities |
| 12/11/2013 | CN103435701A Pig antibacterial peptide cystatin11 fusion protein, and encoding gene and application thereof |
| 12/11/2013 | CN103435700A An insulinotropic complex using an immunoglobulin fragment |
| 12/11/2013 | CN103435699A An insulinotropic complex using an immunoglobulin fragment |
| 12/11/2013 | CN103435698A Sclerostin结合剂 Sclerostin binding agents |
| 12/11/2013 | CN103435694A Smoothened多肽及使用方法 Smoothened polypeptide and methods of use |
| 12/11/2013 | CN103435692A Application of ginseng glycoprotein in medicaments and health-care foods for treating senile dementia |
| 12/11/2013 | CN103435686A Polypeptide Cbf-14 resisting infection of drug-resistant bacteria and application thereof |
| 12/11/2013 | CN103435683A SPARC-derived cancer rejection antigen peptide and pharmaceutical comprising the same |
| 12/11/2013 | CN103435638A Boronate ester compounds and pharmaceutical compositions thereof |
| 12/11/2013 | CN103432681A Medicine preparation and device comprising NRG (neuregulin) |
| 12/11/2013 | CN103432593A Medicine composition for preventing or treating esophageal carcinoma |
| 12/11/2013 | CN103432576A Ovomucin liquid preparation and preparation method thereof |
| 12/11/2013 | CN103432575A Composite biological agent for treating neurodermatitis |
| 12/11/2013 | CN103432574A Application of peroxidase to preparation of drug for preventing and treating cerebrovascular diseases |
| 12/11/2013 | CN103432573A Recombinant human serum albumin-interferon alpha fusion protein water solution and preparation method thereof |
| 12/11/2013 | CN103432572A Rhesus monkey diabetic nephropathy model preparation method |
| 12/11/2013 | CN103432571A Fire-fighting emergency disinfectant towel |
| 12/11/2013 | CN103432570A Thymalfasin sustained-release microspheres and preparation method thereof |
| 12/11/2013 | CN103432569A Recombinant human serum albumin-interferon alpha fusion protein water solution and preparation method thereof |
| 12/11/2013 | CN103432568A Activin-ActRIIa antagonists and uses for promoting bone growth |
| 12/11/2013 | CN103432567A Method for preparing donkey-hide gelatin plasma substitute injection |
| 12/11/2013 | CN103432566A Oligosaccharide-protein conjugates |
| 12/11/2013 | CN103432084A Preparation method of thymopentin freeze-dried powder injection |
| 12/11/2013 | CN103005466B Application for drone pupae polypeptide extract |
| 12/11/2013 | CN102898512B Recombinant plectasin as well as preparation method and application of recombinant plectasin |
| 12/11/2013 | CN102885301B Composition for enhancing immunity and preparation method thereof |
| 12/11/2013 | CN102757564B Preparation method and application of tree-like polyester-polyglycidol block polymer |
| 12/11/2013 | CN102755637B Composition for preventing and treating ischemia reperfusion injury |
| 12/11/2013 | CN102727469B Dry powder inhalant of interferon alpha |
| 12/11/2013 | CN102688496B CTX (Cyclophosphamide)-mediated targeting nanocarrier and nano medicine carrying system |
| 12/11/2013 | CN102688477B Medicinal composition for treating respiratory diseases of livestock |
| 12/11/2013 | CN102614493B Liquid pharmaceutical composition containing echinocandin antifungal agent caspofungin |
| 12/11/2013 | CN102614492B Liquid pharmaceutical composition containing echinocandin antifungal agent micafungin |
| 12/11/2013 | CN102470150B A therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes |
| 12/11/2013 | CN102464704B Novel compound, its preparation method and application |
| 12/11/2013 | CN102166347B New medicinal application of interleukin-12 |
| 12/11/2013 | CN101935345B Peptides and APL-type derivatives of HSP60 and pharmaceutical compositions |
| 12/11/2013 | CN101914161B Fusion protein HGF alpha-Fc for restraining tumor growth and application thereof |
| 12/11/2013 | CN101869716B System for monitoring bacterial tumor treatment |
| 12/11/2013 | CN101674812B Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein |
| 12/11/2013 | CN101636408B 肽 Peptide |
| 12/11/2013 | CN101534648B Methods of treating neuronal disorders using mntf peptides and analogs thereof |
| 12/11/2013 | CN101453891B Administration of the reg1 anticoagulation system |
| 12/11/2013 | CN101111515B Pancreatic polypeptide family motifs, polypeptides and methods comprising the same |
| 12/11/2013 | CN101072572B Isolation of bone marrow fraction rich in connective tissue growth components and the use thereof to promote connective tissue formation |
| 12/10/2013 | US8604281 Transgenic plants with controlled distribution of a trait to progeny |
| 12/10/2013 | US8604169 Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer |
| 12/10/2013 | US8604168 Glycomacropeptide medical foods for nutritional management of phenylketonuria and other metabolic disorders |
| 12/10/2013 | US8604165 Influenza inhibiting compositions and methods |
| 12/10/2013 | US8604164 High purity lipopeptides |
| 12/10/2013 | US8604070 Use of inhibitors of the renin-angiotensin system |
| 12/10/2013 | US8604060 Use of antagonists of the CBI receptor for the manufacture of a composition useful for the treatment of hepatic diseases |
| 12/10/2013 | US8603988 Ionic complexes |
| 12/10/2013 | US8603987 Monoclonal antibodies to fibroblast growth factor receptor 2 |
| 12/10/2013 | US8603986 Compounds and methods for modulating cadherin-mediated processes |
| 12/10/2013 | US8603983 Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions |
| 12/10/2013 | US8603982 Medical composition |
| 12/10/2013 | US8603981 Use of glutamate, glutamate derivatives or metabolites, glutamate analogues or mixtures thereof for the manufacture of a composition for the treatment of osteoporosis |